Benidipine stimulates nitric oxide synthase and improves coronary circulation in hypertensive rats

American Journal of Hypertension

Volumn 12, Issue 5, 1999, Pages 483-491

  Kobayashi, Naohiko ^a   Kobayashi, Kiminari ^a   Hara, Kazuyoshi ^a   Higashi, Teruo ^a   Yanaka, Hatsuko ^a   Yagi, Shigeru ^a   Matsuoka, Hiroaki ^a  

^a Department of Medicine   (Japan)

Author keywords

Calcium antagonist; Coronary circulation; Hypertension; Microspheres; Nitric oxide synthase

Indexed keywords

BENIDIPINE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CAPILLARY DENSITY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG ACTIVITY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; HEART LEFT VENTRICLE; HEART MUSCLE FIBROSIS; HYPERTENSION; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT OUTCOME;

EID: 0032966320     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00260-X     Document Type: Article

References (44)

1. Canby C.A., Tomanek R.J. Role of lowering arterial pressure on maximal coronary flow with and without regression of cardiac hypertrophy. Am J Physiol. 257:1989;H1110-H1118.
2. Ishihara K., Zile M.R., Nagatsu M., et al. Coronary blood flow after the regression of pressure-overload left ventricular hypertrophy. Circ Res. 71:1992;1472-1481.
3. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 329:1993;2002-2012.
4. Dominiczak A.F., Bohr D.F. Nitric oxide and its putative role in hypertension. Hypertension. 25:1995;1202-1211.
5. Palmer R.M.J., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666.
6. Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arterial tone in man. Lancet. ii:1989;997-1000.
7. Konishi M., Su C. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension. 5:1983;881-886.
8. Panza J.A., Casino P.R., Kilcoyne R.N., Quyyumi A.A. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 87:1993;1468-1474.
9. Tesmafariam B., Halpern W. Endothelium-dependent and endothelium-independent vasodilators in resistance arteries from hypertensive rats. Hypertension. 11:1988;440-444.
10. Lüscher T.F., Vanhoutte P.M. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension. 8:1986;344-348.
11. Tchudi M.R., Criscione L., Novosel D., et al. Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats. Circulation. 89:1994;2212-2218.
12. Clozel M., Kuhn H., Hefti F. Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension. 16:1990;532-540.
13. Panza J.A., Quyyumi A.A., Callahan T.S., Epstein S.E. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol. 21:1993;1145-1151.
14. Kojda G., Klaus W., Werner G., Fricke U. Reduced responses of nitrendipine in PGF2- precontracted porcine isolated arteries after pretreatment with methylene blue. Basic Res Cardiol. 85:1990;461-466.
15. Gunther J., Dhein R., Rosen W., et al. Nitric oxide (EDRF) enhances the vasorelaxing effect of nitrendipine in various isolated arteries. Basic Res Cardiol. 87:1992;452-460.
16. Dohi Y., Kojima M., Sato K. Benidipine improves endothelial function in renal resistance arteries of hypertensive rats. Hypertension. 28:1996;58-63.
17. Dohi Y., Criscione L., Pfeiffer K., Lüscher T.F. Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension studies in perfused mesenteric resistance arteries . J Cardiovasc Pharmacol. 24:1994;372-379.
18. Karasawa A., Kubo K. Calcium antagonistic effects and the in vitro duration of actions of KW-3049, a new 1,4-dihydrophyridine derivative, in isolated canine coronary arteries. Jpn J Pharmacol. 47:1988;35-44.
19. Karasawa A., Kubo K., Oka T., Nakamizo N. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious spontaneously hypertensive rats. Arzneimittelforschung. 38:1988;1691-1694.
20. Kobayashi N., Kobayashi K., Kouno K., et al. Effect of benidipine on microvascular remodeling and coronary flow reserve in two-kidney one clip Goldblatt hypertension. J Hypertens. 15:1997;1285-1294.
21. Kobayashi K., Tarazi R.C. Effect of nitrendipine on coronary flow and ventricular hypertrophy in hypertension. Hypertension. 5:(suppl II):1983;II-45-II-51.
22. Kobayashi K., Tarazi R.C. The chronic effect of nitrendipine on heart and regional blood flow in renovascular hypertensive rats. Jpn Circ J. 51:1987;1027-1034.
23. Frohlich E.D., Horinaka S. Cardiac and aortic effects of angiotensin converting enzyme inhibitors. Hypertension. 18:(suppl II):1991;2-7.
24. Tojo A, Kobayashi N, Kimura K, et al: Effects of antihypertensive drugs on nitric oxide synthase activity in rat kidney. Kidney Int 1996;49(suppl 55):S-138-S-140.
25. Takanohashi A., Tojo A., Kobayashi N., et al. Effect of trichlormethiazide and captopril on nitric oxide synthase activity in the kidney of deoxycorticosterone acetate-salt hypertensive rats. Jpn Heart J. 37:1996;251-259.
26. Numaguchi K., Egashira K., Takemoto M., et al. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension. 26:(part 1):1995;957-962.
27. Clozel J.P., Kuhn H., Hefti F. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension. J Hypertens. 7:1989;267-275.
28. Wicker P., Tarazi R.C. Importance of injection site for coronary blood flow determinations by microspheres in rats. Am J Physiol. 242:1982;H94-H97.
29. Kobayashi K., Tarazi R.C., Lovenberg W., Rakusan K. Coronary blood flow in genetic cardiac hypertrophy. Am J Cardiol. 53:1984;1360-1364.
30. Wicker P., Tarazi R.C., Kobayashi K. Coronary blood flow during the development and regression of left ventricular hypertrophy in renovascular hypertensive rats. Am J Cardiol. 51:1983;1744-1749.
31. Kobayashi N., Kobayashi K., Kouno K., et al. Effects of intra-atrial injection of colored microspheres on systemic hemodynamics and regional blood flow in rats. Am J Physiol. 266:1994;H1910-H1917.
32. Kobayashi N., Kobayashi K., Kouno K., et al. Effects of microsphere suspension agents on systemic hemodynamics in rats comparison of nonradioactive colored and radioactive microspheres . Jpn Heart J. 35:1994;467-475.
33. Hale S.L., Alker K.J., Kloner R.A. Evaluation of nonradioactive colored microspheres for measurement of regional myocardial blood flow in dogs. Circulation. 78:1988;428-434.
34. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
35. Hattori Y., Gross S.S. characterization, sequence and relationship to nitric oxide synthase. Biochem Biophys Res Commun. 195:1993;435-441.
36. Seki T., Naruse M., Naruse K., et al. Gene expression of endothelial type isoform of nitric oxide synthase in various tissues of stroke-prone spontaneously hypertensive rats. Hypertens Res. 20:1997;43-49.
37. Terada Y., Tomita K., Nonoguchi H., Marumo F. Polymerase chain reaction localization of constitutive nitric oxide synthase and soluble guanylate cyclase messenger RNAs in microdissected rat nephron segments. J Clin Invest. 90:1992;659-665.
38. Hattori Y., Akimoto K., Murakami Y., Kasai K. Pyrrolidine dithiocarbamate inhibits cytokine-induced VCAM-1 gene expression in rat cardiac myocytes. Mol Cell Biochem. 177:1997;177-181.
39. Lüscher T.F., Vanhoutte P.M. The Endothelium Modulator of Cardiovascular Function . 1991;CRC Press, Boca Raton FL.
40. Vilaine J.P., Biondi M.L., Villeneuve N., et al. The calcium channel antagonist S 11568 causes endothelium-dependent relaxation in canine arteries. Eur J Pharmacol. 197:1991;41-48.
41. Zhang X., Hintze T. Amlodipine releases nitric oxide from canine coronary microvessels. An unexpected mechanism of action of a calcium channel-blocking agent. Circulation. 97:1998;576-580.
42. Kelm M., Preik M., Hafner D.J., Strauer B.E. Evidence for a multifactorial process involved in the impaired flow response to nitric oxide in hypertensive patients with endothelial dysfunction. Hypertension. 27:(part 1):1996;346-353.
43. Ross R. The pathogenesis of atherosclerosis an update . N Engl J Med. 314:1986;488-500.
44. Clozel M., Kuhn H., Hefti F., Baumgartner H.R. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension effect of angiotensin converting enzyme inhibition . Hypertension. 18:1991;132-141.